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Abstract
Heterotrimeric protein phosphatase 2A (PP2A) consists of catalytic C (PP2Ac), structural A, and regulatory B-type
subunits, and its dysfunction has been linked to cancer. Reversible methylation of PP2Ac by leucine carboxyl
methyltransferase 1 (LCMT-1) and protein phosphatase methylesterase 1 (PME-1) differentially regulates B-type
subunit binding and thus PP2A function. Polyomavirus middle (PyMT) and small (PyST) tumor antigens and
SV40 small tumor antigen (SVST) are oncoproteins that block PP2A function by replacing certain B-type subunits,
resulting in cellular transformation. Whereas the B-type subunits replaced by these oncoproteins seem to exhibit a
binding preference for methylated PP2Ac, PyMT does not. We hypothesize that circumventing the normal cellular
control of PP2A by PP2Ac methylation is a general strategy for ST- and MT-mediated transformation. Two predic-
tions of this hypothesis are (1) that PyST and SVST also bind PP2A in a methylation-insensitive manner and (2) that
down-regulation of PP2Ac methylation will activate progrowth and prosurvival signaling and promote transforma-
tion. We found that SVST and PyST, like PyMT, indeed form PP2A heterotrimers independently of PP2Ac methyl-
ation. In addition, reducing PP2Ac methylation through LCMT-1 knockdown or PME-1 overexpression enhanced
transformation by activating the Akt and p70/p85 S6 kinase (S6K) pathways, pathways also activated by MT and ST
oncoproteins. These results support the hypothesis that MT and ST oncoproteins circumvent cellular control of
PP2A by methylation to promote transformation. They also implicate LCMT-1 as a negative regulator of Akt and
p70/p85 S6K. Therefore, disruption of PP2Ac methylation may contribute to cancer, and modulation of this meth-
ylation may serve as an anticancer target.
Neoplasia (2012) 14, 585–599
Introduction
Protein phosphatase 2A (PP2A) is a major serine/threonine phospha-
tase found in all eukaryotic cells, which regulates numerous cellular
events related to normal growth, including but not limited to cell pro-
liferation, survival, and translation [1]. PP2A is typically a negative
regulator of these processes, preventing uncontrolled cell growth
and, consequently, cancer. PP2A most commonly exists as a hetero-
trimer composed of a structural A subunit, a catalytic C subunit
(PP2Ac), and a regulatory B-type subunit. With two distinct isoforms
of both the A and C subunits (α and β) and more than 20 regulatory
B-type subunits encompassing four largely unrelated families (B/PPP2R2,
B′/PPP2R5, B″/PPP2R3, and B‴/STRN), more than 80 different PP2A
holoenzymes may exist [2]. This large number of heterotrimeric forms
facilitates PP2A-mediated regulation of a wide variety of substrates and
pathways, including the growth and survival-related Akt, p70/p85 S6
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kinase (S6K), and mitogen-activated protein kinase/extracellular signal–
regulated kinase pathways, among many others [3,4].
PP2A heterotrimer formation is regulated in part by the reversible
methylation of the α-carboxyl group of the PP2A catalytic C subunit
carboxyl-terminal leucine 309 (L309) [5–8]. Leucine carboxyl methyl-
transferase 1 (LCMT-1) methylates PP2Ac [9], whereas protein phos-
phatase methylesterase 1 (PME-1) serves as the PP2Ac demethylase
[10,11]. The methylation status of PP2Ac alters the composition of
PP2A by differentially modulating the recruitment of certain regulatory
B-type subunits to the core A/C heterodimer [5–8]. For example,
PP2Ac methylation is required for the efficient formation of hetero-
trimers containing the Bα subunit [5,8] and enhances heterotrimer
formation for some B′ family members [5,7,12]; however, PP2Ac
methylation is not necessary for the formation of heterotrimers contain-
ing the B‴ B-type subunits [8]. Therefore, control of PP2Ac methylation
through LCMT-1 and PME-1 is important for regulating the formation
and function of PP2A heterotrimers containing methylation-sensitive
B-type subunits, that is, B-type subunits whose incorporation into PP2A
heterotrimers is enhanced by methylation of PP2Ac. Given that these
methylation-sensitive B-type subunits have been implicated in control
of cell growth and survival (for examples, see References [13–16]), one
important role of PP2Ac methylation may be to coordinately regulate
multiple B-type subunits to negatively regulate cell proliferation and
survival. If this is the case, LCMT-1 may be important for PP2A’s
tumor suppressive function. However, the relevance of LCMT-1 to
oncogenic transformation has not been explored.
PP2A was first specifically implicated in cancer when it was identi-
fied as an important target of polyomavirus middle (PyMT) and small
(PyST) tumor antigens and SV40 small tumor antigen (SVST) [17].
The middle (MT) and small (ST) tumor antigens function as viral
B-type subunits, substituting for, and thus inhibiting the function of,
certain cellular PP2A B-type subunits [17–21]. MT and ST oncopro-
teins only replace a portion of B-type subunits in a transformed cell
[18,22,23]. Therefore, it is important to identify the nature of the
cellular B-type subunits that are replaced by MT and ST oncoproteins.
While these efforts are still at an early stage, three B-type subunits, Bα,
B′α, and B′γ, have been identified as being targeted for replacement by
MT and/or ST oncoproteins [17,21,23,24]. For example, SVST
replaces Bα [21] and B′α and B′γ [23], consequently activating the
extracellular signal–regulated kinase [21], Akt [25–27], and nuclear
factor κB [28,29] signaling pathways to promote unrestricted growth
and survival and thus transformation.
Interestingly, of the three cellular B-type subunits reported to be
displaced by the MT or ST oncoproteins, two (Bα and B′α) are
methylation-sensitive and one (B′γ) is likely to be methylation-sensitive
[5,7,8,12,30]. An important question is whether incorporation of MT
and ST oncoproteins into PP2A heterotrimers is regulated by PP2Ac
methylation. PyMT forms wild-type levels of PP2A heterotrimers in
the absence of PP2Ac methylation [8,18] but whether SVST or PyST
do is not known.We hypothesize that circumventing the normal cellular
control of PP2A by PP2Ac methylation is an important strategy for ST-
and MT-mediated transformation. Two predictions of this hypothesis
are (1) that SVST and PyST will also form PP2A heterotrimers indepen-
dently of PP2Ac methylation and (2) that down-regulation of PP2Ac
methylation to reduce formation of PP2A heterotrimers containing
methylation-sensitive B-type subunits will activate progrowth and pro-
survival signaling and promote transformation.
Here, we specifically tested whether SVST and PyST form PP2A
heterotrimers in the absence of PP2Ac methylation and investigated
whether reduction in LCMT-1 promotes transformation in an estab-
lished human cell transformation system (HEKTERASB56γ cells
[23]). We found that SVST and PyST, like PyMT, incorporate into
PP2A heterotrimers independently of PP2Ac methylation, suggesting
that circumvention of cellular control of PP2A by methylation may be
a general strategy for MT and ST oncoproteins. We also found that
LCMT-1 knockdown reduces PP2Ac methylation and, consequently,
activates Akt and p70/p85 S6K, enhancing anchorage-independent
growth. Overall, our findings support the hypothesis that replace-
ment of methylation-sensitive cellular B-type subunits by methylation-
insensitive MT and ST oncoproteins is an important strategy in MT- and
ST-mediated transformation. Furthermore, the results are consistent
with the idea that reduction in PP2Ac methylation may contribute to
cancer development and modulation of this methylation may serve as
a therapeutic target for cancer.
Materials and Methods
Cell Culture and Creation of Stable Lines Expressing
LCMT-1–Directed Small Hairpin RNA
HEKTERASB56γ cells are described elsewhere [23] and were
maintained in Dulbecco modified Eagle medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 20 μM L-glutamine,
100 U/ml penicillin G, 100 μg/ml streptomycin, and 250 ng/ml
amphotericin B. To create cells with stable knockdown of LCMT-1
and control cells expressing empty vector, HEKTERASB56γ cells were
infected with lentiviruses expressing an LCMT-1 (L3) small hairpin
RNA (shRNA) or empty vector (pLKO.1) as previously described
[31]. Cells were infected at a multiplicity of infection of 3 to ensure
that more than 95% of cells receive at least one viral particle. The
new cell lines, HEKTERASB56γ-L3 and HEKTERASB56γ-VC, were
expanded and frozen for future experiments. These lines and sub-
sequent lines created from them for this study represent populations
of thousands of different clones rather than individual clones.
Creation of the LCMT-1–Rescue Complementary
DNA Sequence
To create an LCMT-1–rescue construct that expresses LCMT-1
mRNA resistant to the L3 LCMT-1 shRNA, four silent mutations
(depicted here as upper case letters) were introduced by polymerase
chain reaction into the LCMT-1 coding region targeted by the L3
LCMT-1 shRNA: 5′ cgtcgaTatgatggaATtC 3′. The entire complemen-
tary DNA (cDNA) was sequenced to ensure that only the intended
bases were altered.
Creation of HEKTERASB56γ Cells That Stably Express
Akt-AA, PME-1, or an shRNA-Resistant LCMT-1
cDNA sequences encoding dominant-interfering Akt-AA (Akt
T308A/S473A; gift from Dr Wei Zhou) [32], PME-1, or L3
shRNA-resistant LCMT-1 were cloned into the pLenti6-V5-D-Topo
vector using conventional cloning techniques or ligation-independent
cloning. Lentiviruses expressing these proteins were then generated
using Invitrogen’s ViraPower 4-plasmid lentiviral system, and viral titers
were determined. HEKTERASB56γ-L3 knockdown cells were infected
with the LCMT-1–rescue or Akt-AA lentiviruses and cells stably expres-
sing these constructs (termed L3-rescue and L3-Akt-AA, respectively)
were obtained by selecting with 7.5 μg/ml blasticidin S-HCl. Similarly,
HEKTERASB56γ vector control (VC) (pLKO.1) cells were infected
with the PME-1 lentiviruses to create HEKTERASB56γ-PME-1 OE.
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For all three of these lines, VC cell lines were created by infection of
the same cells with lentiviruses containing an empty pLenti6-V5-D-
Topo plasmid.
Antibodies
LCMT-1was detected using an affinity-purified rabbit anti-LCMT-1
polyclonal antibody, RK3110, described previously [31]. Other anti-
bodies used included sepharose bead–conjugated anti–HA-tag antibody
used for immunoprecipitation (F-7 AC; Santa Cruz Biotechnologies,
Santa Cruz, CA), anti-HA antibody used for Western blot analysis
(16B12; Covance, Princeton, NJ), anti-SVST rabbit polyclonal anti-
body (gift from W. Hahn), anti-PyST rabbit polyclonal antibody
[33], PP2A Bα mouse monoclonal antibody (clone 2G9; Millipore,
Bedford, MA), PP2Ac mouse monoclonal antibody (BD Transduction
Laboratories, Franklin Lakes, NJ), unmethylated PP2A C sub-
unit mouse monoclonal antibody (clone 1D6 [7]; available from
Millipore, Santa Cruz Biotechnology, or request to the corresponding
author), p-Akt T308 and p-Akt S473 rabbit monoclonal antibodies
(Epitomics, Burlingame, CA), GAPDH mouse monoclonal antibody
(Abmart, Shanghai, China), Pme1 mouse monoclonal antibody
(B12; Santa Cruz Biotechnology), mouse monoclonal antibodies to
p-S6K (p70 T389 and p85 T412) and total rpS6, and rabbit polyclonal
antibodies to p-GSK3β S9, p-rpS6 S235/236, total Akt, total p70/p85
S6K, and pAkt substrate ((R/K)X(R/K)XX(pT/pS)) obtained from
Cell Signaling Technology (Danvers, MA).
Cell Lysis and Western Analysis
Cells were lysed in an Nonidet P-40–containing lysis buffer (10%
glycerol, 20 mM Tris pH 8.0, 137 mMNaCl) as described previously
[31]. Samples containing equal amounts of protein as determined
by Lowry protein assay (Bio-Rad, Hercules, CA) were analyzed on
SDS-polyacrylamide gels. All experiments were conducted using 10%
SDS-PAGE gels unless otherwise stated in figure legends. Western blot
analysis was performed as described [34], except that secondary anti-
bodies coupled to horseradish peroxidase were used. Bands were visu-
alized by enhanced chemiluminescence and quantitated using a BioRad
Fluor-S Max Chemilumimager and Quantity One software. Statistical
significance was established by Student’s t tests, where P ≤ .05 deter-
mines the threshold for significance. *P ≤ .05; **P ≤ .01.
PP2A C Subunit Methylation Assay
The steady-state level of PP2Ac methylation in lysates was deter-
mined using a monoclonal antibody specific for unmethylated
PP2Ac using our published procedure [8]. Briefly, 20 μl of lysate
from VC and L3 cells was treated either with 50 μl of preneutralized
base solution (80 mM NaOH, 80 mM HCl, and 200 mM Tris
pH 6.8) or with 20 μl of base (200 mM NaOH) to completely
demethylate PP2Ac and then neutralized with 30 μl of neutraliza-
tion buffer (133.3 mM HCl and 333.3 mM Tris pH 6.8) before
being analyzed by Western blot analysis for the level of unmethylated
PP2Ac and α-tubulin (loading control).
Anchorage-Independent Growth
Anchorage-independent growth was assayed by soft agar analysis
as described elsewhere [35,36]. Cells were incubated in agar plates
for 3 weeks at 37°C at 10% CO2 and fed with 0.25 ml of 10%
FBS in DMEM weekly to maintain moisture and nutrients. Colonies
were scored for number and volume using a bench-top microscope
(Olympus CK2; Olympus Corp, Center Valley, PA) equipped with
an eyepiece micrometer reticle. Colonies 0.1 mm in diameter or larger
were counted. All assays were performed three times in triplicate un-
less otherwise specified in the figure legend. Statistical significance was
established by Student’s t tests as described above. Small, representa-
tive microscopic fields within the dishes were photographed at 40×
using an Olympus IX81 microscope (Olympus Corp) equipped with
a Nikon Fi1/U2 color camera (Nikon Instruments, Inc, Tokyo, Japan)
and processed using NIS Elements software.
Suspension Cultures
To analyze biochemical changes in anchorage-independent cells,
cells were plated onto Corning 100-mm ultra-low-attachment culture
dishes at 0.5 million cells/plate and grown for 1 week in DMEM sup-
plemented with 10% FBS. The cells formed spherical colonies similar
to those seen in soft agar, although, because of the lack of matrix,
colonies were not stationary and were sometimes interconnected.
Because of this and the fact that attempts to totally dissociate the cells
to obtain counts resulted in substantial cell lysis, we used total cell
weights as a measure of growth. After 1 week in culture, colonies were
collected, washed, and pelleted, and then all excess fluid was removed
and the cell pellets were weighed on a highly sensitive scale. Cells
were then lysed and analyzed as described previously.
Results
SVST and PyST Do Not Require PP2Ac Methylation for
Heterotrimer Formation
We hypothesized that replacement of methylation-sensitive cellular
B-type subunits by methylation-insensitive viral B-type subunits (MT
and ST) is an important strategy of polyomavirus and SV40 for cir-
cumventing normal control of cell growth and survival during trans-
formation (Figure 1A). To test this hypothesis, we first determined
whether SVST and PyST, like PyMT, form PP2A heterotrimers in-
dependently of PP2Ac methylation. For these experiments, we used
two PP2Ac mutants that had previously been used to distinguish
between methylation-sensitive and methylation-insensitive PP2A
heterotrimer formation: L309Δ, a PP2Ac mutant lacking the methyl-
ated carboxyl-terminal L309, and D85N, an active site PP2Ac mutant
with an intact, but unmethylated L309 [8,30]. Of note, the latter
mutant indirectly inhibits methylation presumably by blocking asso-
ciation with LCMT-1 (mimicking an LCMT-1 knockdown effect)
[37]. We tested whether SVST and PyST could form heterotrimers
containing the L309Δ and D85N mutants by using coimmunoprecip-
itation. SVST and PyST coimmunoprecipitated to the same extent
with wild-type, L309Δ, and D85N PP2Ac (Figure 1, B and C ),
whereas endogenous methylation-sensitive Bα only coimmunoprecip-
itated with wild-type PP2Ac. This result supports the idea that assem-
bly of PP2A heterotrimers containing MT and ST oncoproteins is not
regulated by PP2Ac methylation, whereas formation of at least some of
the key PP2A heterotrimers they replace is regulated by the methylation
status of PP2Ac.
Loss of LCMT-1 Promotes Transformation
A second prediction of our hypothesis is that reducing PP2Ac
methylation by decreasing the level of the methyltransferase responsible
for PP2Ac methylation, LCMT-1, would promote transformation. To
test this prediction, we used a genetically defined transformation sys-
tem in which immortalized primary human embryonic kidney cells
expressing SV40 large tumor antigen, activated H-Ras, and human
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telomerase (HEKTER cells [38]) have been weakly transformed by
down-regulation of the PP2A B-type subunit, B56γ (HEKTERASB56γ
cells [23]). Whereas HEKTER cells can grow indefinitely in culture,
they form very few anchorage-independent colonies in soft agar
[23,38]. When SVST is expressed in the immortalized HEKTER line,
the cells grow robustly in soft agar. Knocking down B56γ, a target of
SVST, in HEKTER cells partially recapitulates SVST-mediated trans-
formation phenotype [23]. We chose to use the weakly transformed
HEKTERASB56γ line for our studies because it would allow us to
determine the cumulative effect of targeting additional methylation-
sensitive B-type subunits and to detect either increased or decreased
transformation on LCMT-1 down-regulation. HEKTERASB56γ cells
were infected with vector control (VC) or LCMT-1–directed (L3)
shRNA virus, and Western blot analysis was used to verify the knock-
down of LCMT-1 (Figure 2A). Quantitation of three independent
experiments showed that the LCMT-1 shRNA stably reduced LCMT-1
expression by 80% ± 6% compared with the VC cells. In addition,
LCMT-1 knockdown reduced the steady-state level of the methylation-
sensitive PP2A Bα subunit (Figure 2A) by 28% ± 15% (P = .03), show-
ing that the LCMT-1 knockdown affects at least one B-type subunit that
depends on LCMT-1 for heterotrimer formation.
Next, we measured the effect of LCMT-1 knockdown on the
steady-state level of PP2Ac methylation using an assay using a mono-
clonal antibody specific for unmethylated PP2Ac (Figure 2B). As can
be seen by comparing the minus base (−) lanes (which show endoge-
nous levels of unmethylated PP2Ac) in Figure 2B, the amount of
unmethylated PP2Ac greatly increased in L3 LCMT-1 knockdown
cells compared with the VC control cells. Quantitation of the results
showed that only 17% of the total PP2Ac in the LCMT-1 knock-
down cells remained methylated compared to 74% methylation in
the control cells (Figure 2C ). Thus, LCMT-1 knockdown reduced
steady-state PP2Ac methylation by more than four-fold.
To examine the role of LCMT-1 and PP2Ac methylation in trans-
formation, VC and L3 cells were evaluated for anchorage-independent
growth in soft agar, an assay highly predictive of tumorigenicity [39].
After 3 weeks of growth in agar, colonies were examined bymicroscopy,
revealing that L3 cells formed larger and more abundant colonies
(Figure 2D). Quantitative analysis showed that L3 cells had a two-fold
increase in colony number (Figure 2E ) and more than a four-fold
increase in colony volume compared to VC cells (Figure 2F ). These
results strongly support the hypothesis that LCMT-1 is a negative reg-
ulator of transformation and are consistent with the idea that circum-
vention of PP2Ac methylation-regulated control of PP2A function
contributes to MT and ST-mediated transformation.
LCMT-1 Knockdown Does Not Affect Cell Size, Proliferation
Rate, Survival, or the Akt and p70/p85 S6K Signaling
Pathways during Normal Anchorage-Dependent Growth
To begin to dissect how a reduction in LCMT-1 promotes
anchorage-independent growth, we tested whether the increase in col-
ony growth of LCMT-1 knockdown cells in soft agar reflects changes
in cell size, cell growth, and/or death rates in standard, anchorage-
dependent tissue culture. VC and L3 cells growing in anchorage-
dependent conditions were analyzed for forward scatter–area (FSC-A)
by flow cytometry, which is a function of relative cell size. In three
independent experiments, FSC-A was not substantially different (Fig-
ure 3A), supporting the conclusion that an increase in cell size on
LCMT-1 knockdown does not account for the increase in the number
and size of L3 colonies in soft agar. Comparison of the proliferation
Figure 1. Unlike the methylation-dependent cellular B-type subunit,
Bα, SVST and PyST can incorporate into PP2A heterotrimers inde-
pendently of PP2Ac carboxyl methylation. (A) The diagram illustrates
a potential strategy of polyomavirus and SV40 in which methylation-
insensitive viral B-type subunits (PyMT, PyST, and SVST) specifically
replace methylation-sensitive cellular B-type subunits (B*), thus pro-
moting transformation by circumventing normal control of PP2A by
methylation. LCMT-1 promotes PP2Ac subunit methylation and the
assembly ofmethylation-sensitive B-type subunits into PP2A hetero-
trimers (B*AC), which block transformation. Specific targeting of
PP2A B*AC complexes byMT and ST oncoproteins promotes trans-
formation. (B and C) HEK 293 cells were cotransfected with empty
vector, HA-tagged wild-type PP2Ac (HA-PP2Ac wt), HA-tagged
PP2Ac D85N mutant, HA-tagged PP2Ac carboxy-terminal leucine
deletion mutant (HA-PP2Ac L309Δ), and SVST (B) or PyST (C) in the
combinations indicated. HA-epitope tagged PP2Ac was immuno-
precipitated 48 hours later with a sepharose bead–conjugated anti-
HA antibody for 1.5 hours at 4°C with rocking to determine the
binding of endogenous Bα and SVST (B) or PyST (C). After washing
twice with PBS and lysis buffer, immune complexes (upper panels)
and lysates (lower panels) were resolved on a 12% SDS-PAGE gel
and probed with antibodies to the HA epitope tag, Bα subunit and
SVST (B), or PyST (C).
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rates of VC and L3 cells over a 1-week period also showed no significant
differences between the two cell lines, indicating that LCMT-1 knock-
down does not increase cell proliferation in anchorage-dependent condi-
tions (Figure 3B). Quantitation of the amount of cell death in VC and
L3 cultures during adherent cell growth also revealed no significant dif-
ference between the cell lines (Figure 3C ). Similarly, no significant dif-
ference in cell death was seen when the VC and L3 cells were exposed to
low serum conditions (0.1% FBS) for 48 hours to stress the cells
(Figure 3D). Thus, under both normal and serum-starved growth con-
ditions, no survival advantage is seen for LCMT-1 knockdown cells
compared with control cells.
To assess whether LCMT-1 knockdown activates progrowth/
prosurvival signaling pathways during anchorage-dependent growth,
Figure 2. Knocking down LCMT-1 promotes transformation. (A)
Knockdown of LCMT-1 in HEKTERASB56γ cells. HEKTERASB56γ
cells stably expressing empty pLKO.1 vector control (VC) or LCMT-1
shRNA (L3) were lysed and LCMT-1 and Bα levels were detected
by Western blot analysis. GAPDH was used as loading control.
(B and C) PP2Ac is highly unmethylated in the LCMT-1 knockdown
line. (B) As described in Materials and Methods, equal volumes of
lysates from VC and L3 cells were either treated with preneutralized
base solution (− lanes; show unmethylated PP2Ac levels in cells) or
base treated to completely demethylate PP2Ac and then neutralized
(+ lanes; 100% demethylated controls) before being analyzed by
Western blot analysis for the level of unmethylated PP2Ac and
α-tubulin (loading control). (C) The percent unmethylated PP2Ac
was determined by quantitatively comparing the unmethylated
PP2Ac signals in the − and + lanes. Percent methylated PP2Ac
was calculated by subtracting percent unmethylated PP2Ac from
100. Graph depicts the average percent methylation of PP2Ac in
VC and L3 lines. Error bars represent SDs of three independent ex-
periments. (D) Anchorage-independent growth of VC and L3 cells
in soft agar. Photographs show small, single, representative fields
within the agar wells. Average colony numbers (E) and average
colony volumes (F) were determined as described in Materials and
Methods, and data are shown in graphs as fold change relative to
VC. Error bars represent SD of three independent experiments
performed in triplicate. *P ≤ .05. **P ≤ .01.
Figure 3. Adherent control and LCMT-1 knockdown lines show no
difference in growth, death, or Akt and S6K signaling. (A) Non-
confluent VC and LCMT-1 knockdown (L3) cells growing on 10-cm
tissue culture dishes for 48 hours were trypsinized, washed, and dis-
persed into single-cell suspensions. About 20,000 cells/sample were
analyzed using an AccuriC6 Flow Cytometer (BD Bioscience, Franklin
Lakes, NJ) to compare cell size as determined by FSC-A. The aver-
age cell size is presented in the graph as fold change relative to VC.
(B) Growth rates of adherent VC and L3 lines were assessed by plat-
ing 10,000 cells on 10-cm dishes on day 0 and collecting and count-
ing all viable cells (adherent and detached) at days 1, 3, and 7. Cells
were stained with Trypan blue to exclude dead cells and counted
with a hemacytometer. Graph represents the average number of
live cells at each time point. (C) The VC and L3 lines were plated at
50,000 cells per 3.5-cm well and grown for 72 hours. Both adherent
and detached cells were collected, stained with Trypan blue to iden-
tify dead cells, and counted with a hemacytometer. The average
percentage of dead cells of the VC and L3 lines is presented in the
graph as percent cell death. (D) VC and L3 cell lines were plated at
50,000 cells/well in triplicate in a six-well dish and cultured in DMEM
supplemented with 10% FBS for 24 hours. Cells were then serum-
starved (0.1% FBS) for 48 hours, and the percentage of dead cells
was determined. The average percentage of dead cells in each line
is presented in the graph. (E-G) Lysates fromadherent VC and L3 cells
were analyzed by Western blot analysis for pAkt T308, pAkt S473,
pGSK3β S9, p-p85 S6K, p-p70 S6K and p-rpS6. GAPDH, total Akt,
total p70 and p85 S6K, and total rpS6 were used as loading controls.
No statistically significant changes were seen in signaling in three
independent experiments. Error bars in all panels represent SD of
three experiments. *P ≤ .05. **P ≤ .01.
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we compared the levels of regulatory phosphorylations on Akt, the Akt
substrate, GSK3β, p70/p85 S6K, and ribosomal protein S6 (rpS6) in
adherent cells. No significant differences in these phosphorylations
were detected between the VC and L3 cells (Figure 3, E-G ). These
results indicate that the activation state of these signaling molecules is
not altered by LCMT-1 knockdown in adherent cultures, consistent
with the lack of effect of LCMT-1 knockdown on proliferation and
survival during normal anchorage-dependent growth.
LCMT-1 Knockdown Activates the Akt and p70/p85 S6K
Pathways in Anchorage-Independent Conditions
Our observation that LCMT-1 knockdown increased colony
number and size in soft agar but had no significant effect on growth
or survival in anchorage-dependent conditions raised the intriguing
possibility that LCMT-1 knockdown might enhance growth and sur-
vival signaling exclusively during anchorage-independent cell growth.
When anchorage-dependent cells are unable to attach to an appropriate
substratum, reduced growth and survival signaling normally occurs, re-
sulting in cessation of cell proliferation and eventually cell death [40].
We hypothesized that LCMT-1 is necessary for the down-regulation
of key proliferation and survival signals in anchorage-independent
conditions and that LCMT-1 knockdown inappropriately maintains
elevated levels of progrowth and prosurvival signaling during anchorage-
independent growth. To test this hypothesis, we analyzed the Akt
and p70/p85 S6K signaling pathways in VC and L3 cells growing in
anchorage-independent conditions on ultra-low-adherence tissue culture
Figure 4. LCMT-1 knockdown activates Akt and S6K signaling in anchorage-independent conditions. (A) Equal numbers of VC and L3 cells
were seeded on low-binding tissue culture dishes to analyze differences during anchorage-independent growth. After 1 week, suspension
cells were weighed to assess growth. In the graph, data are presented as average fold change relative to VC for three independent experi-
ments. (B) Lysates from VC and L3 suspension cells were analyzed by Western blot analysis for changes in activation of Akt. GAPDH and
total Akt were used as loading controls. Western blot analysis for LCMT-1 confirmed the knockdown of LCMT-1 in suspension cultures.
(C) Graph depicts the average levels of phospho-Akt T308, phospho-Akt S473, and phospho-GSK3β S9 in three independent immunoblot
experiments as fold change relative to VC. (D) An anti-Akt phospho-substrate motif (R/K)X(R/K)XX(pT/pS) antibody was used to probe the VC
and L3 suspension cell lysates. Arrows highlight some proteins with increased phosphorylation in the L3 cells relative to VC. Bracket with
asterisk indicates phospho-rpS6, which is known to cross-react with this antibody. (E and F) Lysates were probed for changes in p70 and
p85 S6K activation and rpS6 phosphorylation. Total p70 and p85 S6K and total rpS6 were used as loading controls. (G) Graph represents
average fold change in the levels of phospho-p85, phospho-p70 and phospho-rpS6 in three independent immunoblot experiments relative
to VC. Experiments were performed in triplicate and error bars in all panels represent SD. *P ≤ .05. **P ≤ .01.
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dishes. In these dishes, both the VC and L3 cell lines proliferate and
form spherical, anchorage-independent clusters of cells. Similar to results
from soft agar growth, the LCMT-1 knockdown cells showed a selective
advantage over the control cells as indicated by a 70% increased total
weight of the L3 cells compared with the VC cells after 1 week of growth
under these conditions (Figure 4A). Considering the difference in assay
time, we would expect that the L3 suspension colonies would have had
a similar growth differential to the VC line as seen in soft agar if they
were grown for 3 weeks in suspension cultures. Western blot analysis
of the VC and L3 cell suspension cultures revealed a number of pro-
growth and prosurvival signaling differences. Relative to VC cells, L3 cells
have increased activated Akt as indicated by increased phosphorylation
at both T308, which is located in the kinase domain, and S473, which
is located in the C-terminal regulatory domain (Figure 4, B and C ).
Phosphorylation of these two sites is carried out by different kinases,
and while phosphorylation of T308 partially activates Akt, full activation
requires phosphorylation at both sites [41]. Furthermore, a downstream
target of the Akt cell growth and survival pathway, GSK3β, showed
significantly increased phosphorylation on Ser9 in L3 cells (Figure 4, B
andC ). Phosphorylation of Ser9 onGSK3β is inhibitory and would thus
be expected to reduce the reported proapoptotic activities of GSK3β
[42]. To further examine activation of Akt, we probed lysates from these
cells with a phospho-Akt substrate antibody that specifically recognizes
the (R/K)X(R/K)XX(pT/pS) motif when it is phosphorylated on the
serine/threonine residue. Consistent with our finding of increased acti-
vated Akt on LCMT-1 knockdown, this antibody detected substantial
increases in the phosphorylation of a number of proteins in L3 cells
compared to VC cells (Figure 4D).
The (R/K)X(R/K)XX(pT/pS) substrate phosphorylation motif is
also shared with S6K; therefore, some of the proteins with increased
phosphorylation in the L3 lane of Figure 4D could be p70/p85 S6K sub-
strates. For example, the bracketed protein of ∼30 kDa in Figure 4D is
likely rpS6, which is a substrate for p70 S6K but not Akt. Probing for
activating phosphorylations on p70/p85 S6K showed that these kinases
are indeed activated by LCMT-1 knockdown (Figure 4, E and G ).
Immunoblot analysis with phospho-rpS6 and total rpS6 antibodies
alsoconfirmed that LCMT-1 knockdown increases rpS6 phosphoryla-
tion on a site that correlates with increased protein translation [43,44]
(Figure 4, F and G ). These results support the idea that LCMT-1
knockdown increases survival in an anchorage-independent environ-
ment through modulation of the Akt and p70/p85 S6K pathways.
Effects of LCMT-1 Knockdown on Growth and Signaling Are
Rescued by Exogenous Expression of LCMT-1
To confirm that the effects of enhanced transformation and altered
signaling in the LCMT-1 knockdown line are specifically due to de-
creased LCMT-1, we tested whether the effects of LCMT-1 knock-
down could be rescued by exogenously expressing LCMT-1. To
accomplish this, the original VC cells were infected with an empty ex-
pression vector (creating VC-control cells) and the original LCMT-1
knockdown cells (L3) were infected with either an empty vec-
tor (creating L3-control cells) or a vector expressing an L3 shRNA-
resistant LCMT-1 mRNA (creating L3-rescue cells). Western blot
analysis verified that LCMT-1 remained knocked down in the L3-
control line and that LCMT-1 protein expression was rescued in the
L3-rescue line (Figure 5A). Analysis of the level of PP2Ac methylation
in these cell lines demonstrated that restoration of LCMT-1 expression
restored the normal level of PP2Ac methylation in the L3-rescue cells
(Figure 5, B and C ). To examine the ability of exogenous LCMT-1
expression to rescue the effect of LCMT-1 knockdown on transforma-
tion, VC-control, L3-control, and L3-rescue lines were subjected to soft
agar analysis. The number of colonies produced by the L3-rescue cells
was reduced almost three-fold from the L3-control cells and was com-
parable to the VC-control cells (Figure 5,D and E ), indicating that loss
of LCMT-1 was indeed responsible for the increase in colony number
observed on LCMT-1 knockdown. LCMT-1 reexpression (L3-rescue)
also significantly reversed colony size compared to the LCMT-1 knock-
down cells (L3-control; Figure 5, D and F ). These results support the
conclusion that reduction of LCMT-1 enhances transformation in the
HEKTERASB56γ cell line, presumably by hampering PP2A’s tumor
suppressor function. Consistent with the hypothesis that LCMT-1 has
a tumor suppressor function, overexpression (OE) of LCMT-1 in
HEKTERASB56γ VC cells also substantially reduced both colony
Figure 5. Effects of LCMT-1 knockdown on transformation are
rescued by expression of an shRNA-resistant LCMT-1. (A) Rescue
of the LCMT-1 knockdown line. Lysates from VC and L3 cells stably
expressing an empty control plasmid (VC-control and L3-control,
respectively) and L3 LCMT-1 knockdown cells stably expressing
an LCMT-1 rescue plasmid (L3-rescue) were analyzed by Western
blot analysis for LCMT-1 protein expression. (B and C) PP2Ac
methylation is rescued in the L3 rescue cell line. (B) Equal vol-
umes of lysates from VC-control, L3-control, and L3-rescue were
either treated with preneutralized base solution (− lanes; show
unmethylated PP2Ac levels in cells) or base treated and then neu-
tralized (+ lanes; 100% demethylated controls) before being
analyzed by Western blot analysis for the level of unmethylated
PP2Ac and α-tubulin (loading control). (C) Graph depicts the average
percent methylation of PP2Ac in the lysates, calculated as described
in the legend to Figure 2C . (D) Anchorage-independent growth of
VC-control, L3-control, and L3-rescue cells in soft agar. Photographs
show small, single, representative fields within the agars. Average
colony numbers (E) and average colony volumes (F) were deter-
mined, and data are shown in graphs as fold change relative to
VC-control. Error bars in all panels represent SD of three independent
experiments. *P ≤ .05. **P ≤ .01.
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number and volume in soft agar (data not shown). Together, these data
argue that loss of PP2A methylation promotes transformation, whereas
increasing PP2A methylation reduces transformation.
To determine whether reexpression of LCMT-1 in L3 cells reverses
the changes in the Akt and p70/p85 S6K signaling pathways induced by
LCMT-1 knockdown, the VC-control, L3-control, and L3-rescue cells
were grown in suspension in ultra-low-adherent culture dishes. Reexpres-
sion of LCMT-1 completely reversed the anchorage-independent
growth advantage observed in L3-rescue cells (Figure 6A). Correspond-
ingly, the phosphorylation levels of T308 and S473 on Akt and of S9 on
GSK3β were fully reversed to control levels (Figure 6, B and C ; compare
L3 rescue to VC-control). Levels of phosphorylation on (R/K)X(R/K)
XX(pT/pS) motif-containing proteins were also reversed to control levels
(Figure 6D). Lastly, Western blot analysis revealed that reexpression of
LCMT-1 fully reversed the activation of p70/p85 S6K and rpS6 phos-
phorylation (Figure 6, E-G ). These results demonstrate that the signaling
Figure 6. Effects of LCMT-1 knockdown on biochemical signaling are rescued by reexpression of LCMT-1. (A) Normalization of anchorage-
independent growth by LCMT-1 reexpression. Anchorage-independent growth of VC-control, L3-control, and L3-rescue cells (defined in
Figure 5A) were assessed as in Figure 4A by weighing cells after 1 week in suspension culture. Data are presented as fold-change relative
to VC. (B, C, and D) Normalization of Akt signaling by LCMT-1 reexpression. (B) Lysates from VC-control, L3-control, and L3-rescue suspen-
sion cells were analyzed by Western blot analysis for changes in activation of Akt. GAPDH and total Akt were used as loading controls. (C)
Graph depicts the average fold change in the levels of phospho-Akt T308, phospho-Akt S473, and phospho-GSK3β S9 in three immunoblot
experiments relative to VC-control. (D) Akt phospho-substrate antibody was used to probe lysates from the VC-control, L3-control, and L3-
rescue lines. Arrows indicate some proteins whose phosphorylation increased on L3 knockdown but returned to control levels on reexpres-
sion of LCMT-1. Bracket indicates phospho-rpS6. (E and F) Rescue of S6K activation and rpS6 phosphorylation by LCMT-1 reexpression.
Lysates were probed for changes in the activation state of p70 and p85 S6K and rpS6 phosphorylation. Total p70 and p85 S6K and total
rpS6 were used as loading controls. (G) Graph represents average fold change in the levels of phospho-p85, phospho-p70, and phospho-
rpS6 in three immunoblot experiments relative to VC-control. Error bars in all panels represent SD of three independent experiments.
*P ≤ .05. **P ≤ .01.
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Figure 7. Akt activation is necessary for the enhanced transformation caused by LCMT-1 knockdown. (A) Lysates from VC and L3
cells stably expressing an empty control plasmid (VC-control and L3-control, respectively) and lysates from L3 cells stably expressing
dominant-negative Akt-AA (L3-Akt-AA) were analyzed by Western blot analysis for the expression of Akt-AA, LCMT-1, and GAPDH.
(B) knockdownknockdownAnchorage-independent growth of VC-control, L3-control, and L3-Akt-AA cells in soft agar. Photographs show
small, single, representative fields within the agars. Average colony numbers (C) and average colony volumes (D) were determined, and data
are shown in graphs as fold change relative to VC-control. Error bars represent SD of three independent experiments performed in triplicate.
(E) Lysates fromVC-control, L3-control, and L3-Akt-AA suspension colonieswere analyzed byWestern blot analysis for changes in activation
of endogenous Akt. GAPDH was used as a loading control. (F) Graph depicts the average fold change in the levels of phospho-Akt T308,
phospho-Akt S473, and phospho-GSK3β S9 in three immunoblot experiments relative to VC-control. (G) Probing of VC-control, L3-control,
and L3-Akt-AA lysates with phospho-Akt substrate antibody shows that dominant-negative Akt expression prevents the increased phos-
phorylation of many proteins caused by LCMT-1 knockdown (arrows show examples). The bracket with asterisk indicates phospho-rpS6,
which ran at the bottom of this 7.5% SDS-PAGE gel. (H and I) Lysates were probed for changes in p70 and p85 S6K activation and rpS6
phosphorylation. Total p70 and p85 S6K and total rpS6 were used as controls. (J) Graph depicts the average fold change in the levels of
phospho-p85, phospho-p70, and phospho-rpS6 in three immunoblot experiments relative to VC-control. Error bars represent SD of three
independent experiments. For all graphs: *P ≤ .05. **P ≤ .01.
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changes detected in this system upon LCMT-1 knockdown are due spe-
cifically to reduction in the LCMT-1 protein level. They also support the
hypothesis that that loss of PP2A methylation promotes transformation,
although we cannot rule out a possible contribution of a yet to be
discovered LCMT-1 target.
Akt Activation Is Necessary for the Enhanced Transformation
Caused by LCMT-1 Knockdown
To test the hypothesis that LCMT-1 knockdown increases trans-
formation through activating the Akt survival pathway, we expressed
a dominant-negative Akt (Akt-AA) in LCMT-1 (L3) knockdown
cells (creating L3-Akt-AA cells). VC-control, L3-control, and L3-
Akt-AA cell lines were analyzed by Western blot to confirm the
expression of the mutant Akt construct and the maintenance of
LCMT-1 knockdown in L3-Akt-AA cells (Figure 7A). These lines were
then subjected to soft agar analysis to assay for anchorage-independent
growth. The expression of Akt-AA completely reversed the increase in
colony number (∼2.4-fold) observed upon LCMT-1 knockdown and
reduced the average colony volume of LCMT-1 knockdown cells by
more than 2.3-fold (Figure 7, B-D). In contrast, the expression of
Akt-AA in HEKTERASB56γ VC cells resulted in only a ∼30% reduc-
tion in soft agar colony number that was not statistically significant
and reduced colony size by only 6% in soft agar (data not shown),
indicating that the effect of expressing the kinase-deficient Akt in L3
knockdown cells is largely specific for LCMT-1.
To examine the effect of dominant-negative Akt-AA expression
on Akt signaling, VC-control, L3-control, and L3-Akt-AA cells
were grown in suspension and analyzed by Western blot. Akt S473
phosphorylation and GSK3β S9 phosphorylation were reduced to con-
trol levels, whereas Akt T308 phosphorylation was partially reduced but
not significantly (Figure 7, E and F ). Immunoblot analysis with the
(R/K)X(R/K)XX(pT/pS) motif antibody showed that phosphorylation
of most proteins affected by LCMT-1 knockdown was also reversed to
control levels (Figure 7G ). Lastly, we probed lysates from these lines for
p70/p85 S6K activating phosphorylations and phosphorylation of
rpS6. p70/p85 S6K activating phosphorylations were substantially
and significantly reduced in L3-Akt-AA cells as was rpS6 phosphoryla-
tion (Figure 7, H-J ). Together, these results show that Akt signaling is
required for the enhanced transformation caused by LCMT-1 knock-
down and for much of the p70/p85 S6K pathway activation.
Overexpression of the PP2Ac Methylesterase, PME-1, Causes
Similar Changes in Anchorage-Independent Growth and
Signaling As LCMT-1 Knockdown
PME-1 overexpression provides another approach to test the ef-
fects of reduced PP2A methylation on transformation. To determine
whether PME-1 overexpression would cause the same effects as
LCMT-1 knockdown, we overexpressed PME-1 in HEKTER-
ASB56γ cells (creating PME-1 OE cells). VC and PME-1 OE cells
were analyzed by Western blot analysis to verify PME-1 expression
(Figure 8A ). PP2Ac methylation in cell lysates was reduced from
81% for VC cells to 26% for PME-1 OE cells (Figure 8, B and C ).
Results of experiments evaluating anchorage-independent growth
in soft agar showed that PME-1 overexpression significantly increases
colony number, but not colony volume (Figure 8, D-F ). Western blot
analysis of VC and PME-1 OE suspension cell lysates for changes in
the Akt and p70/p85 S6K pathways showed that PME-1 overexpres-
sion significantly increased T308 phosphorylation on Akt but not
S473 phosphorylation on Akt or pGSK3β S9 phosphorylation (Fig-
ure 8, G and H ). Probing lysates from VC and PME-1 OE cells with
(R/K)X(R/K)XX(pT/pS) substrate motif antibody demonstrated that
PME-1 overexpression increased the phosphorylation of several pro-
teins migrating at positions of proteins whose phosphorylation was
increased in LCMT-1 knockdown cells (compare Figure 8I to Fig-
ure 4D). Lastly, activating phosphorylation of p70/p85 S6K and phos-
phorylation of rpS6 were significantly increased (Figure 8, J-L). These
results show that overexpression of PME-1 reduces PP2Ac methylation,
increases transformation, and alters Akt and p70/p85 S6K signaling in
a manner similar to LCMT-1 knockdown.
Discussion
Our results demonstrate that SVST and PyST, like PyMT, form
heterotrimers with PP2A in a methylation-insensitive manner. In addi-
tion, reducing PP2Ac methylation by knocking down LCMT-1 or
overexpressing PME-1 enhances progrowth and prosurvival signaling,
promoting transformation in the genetically defined HEKTERASB56γ
human cell system. Overall, these results lead us to propose a model for
MT and ST oncoprotein-mediated transformation in which methylation-
insensitive viral B-type subunits (MT and ST) replace methylation-
sensitive cellular PP2A B-type subunits to circumvent the antigrowth,
antiproliferative effects of methylation-sensitive PP2A heterotrimers
(Figure 9). The fact that both polyomavirus and SV40 oncoproteins form
PP2A heterotrimers independent of the methylation status of PP2Ac
suggests that circumventing control by PP2Ac methylation is a general
strategy for MT and ST-mediated transformation. Together, these
results provide new insight into the mechanism of transformation by
MTand SToncoproteins and are consistentwith the idea that a reduction
in LCMT-1 amount or activity could contribute to human cancer.
LCMT-1 knockdown in HEKTERASB56γ cells increased both the
number and size of the colonies observed in soft agar assays, indicating
that loss of LCMT-1 causes additional signaling changes to those
already present in the HEKTERASB56γ cells. Activation of Akt, which
was demonstrated by both direct measurement of activating phosphor-
ylations and analysis of downstream signaling, was required for LCMT-
1 knockdown-induced transformation. Phosphorylation of Akt T308
was particularly increased on LCMT-1 knockdown, suggesting that this
phosphorylation site may be regulated directly or indirectly by one or
more methylation-sensitive PP2A B-type subunits. Consistent with this
possibility, the highly methylation-sensitive PP2A Bα subunit has been
reported to direct the dephosphorylation of Akt T308 [13]. Another
possible candidate is B′β, which has been reported to negatively regulate
Akt T308 phosphorylation and seems to be methylation-sensitive
[12,15]. Akt S473 phosphorylation, however, is regulated by PP2A B′γ
(B56γ) [14], which is knocked down already in the HEKTERASB56γ
cells. LCMT-1 knockdown further increases phosphorylation at this
site, suggesting that LCMT-1 may regulate additional PP2A hetero-
trimeric forms that target Akt S473. Because B′β has also been reported
to promote dephosphorylation of Akt S473 [15], it is a possible target
for LCMT-1–mediated effects. Bα and B′α, which are both highly
methylation-sensitive [8,12], do not seem to be candidates for modu-
lation of Akt S473 phosphorylation because Bα or B′α knockdown
does not affect phosphorylation on this site [13,14].
LCMT-1 knockdown also activated p70/p85 S6K and increased
phosphorylation of their downstream target, rpS6, on a site that cor-
relates with increased translation [43,44]. Given that S6K can be
activated by Akt through the mTOR pathway [45,46], much of
the LCMT-1–dependent activation of the S6K pathway might be
a consequence of Akt activation. Consistent with this possibility,
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Figure 8. Overexpression of the PP2A methylesterase, PME-1, enhances transformation, and elicits similar biochemical changes as
LCMT-1 suppression. (A) Lysates from HEKTERASB56γ cells stably expressing either an empty vector (VC) or excess PME-1 (PME-1
OE) were analyzed by Western blot analysis for the expression of PME-1. (B and C) PP2Ac methylation is reduced in the PME-1 OE cell
line. (B) Equal volumes of lysates from VC and PME-1 OE lines were either treated with preneutralized base solution (− lanes; show
unmethylated PP2Ac levels in cells) or base treated and then neutralized (+ lanes; 100% demethylated controls) before being analyzed
by Western blot analysis for the level of unmethylated PP2Ac and α-tubulin (loading control). (C) Graph depicts the average percent
methylation of PP2Ac in the lysates, calculated as described in the legend to Figure 2C . Error bars represent SD of three independent
experiments. (D) Anchorage-independent growth of VC and PME-1 OE cells in soft agar. Photographs show small, single, representative
fields within the agars. Average colony numbers (E) and average colony volumes (F) were determined, and data are shown in graphs as
fold change relative to VC. Error bars represent SD of six independent experiments performed in triplicate. (G) Lysates from VC and PME-1
OE suspension cells were analyzed by Western blot analysis for changes in activation of Akt. GAPDH was used as a loading control. (H)
Graph depicts the average fold change in the levels of phospho-Akt T308, phospho-Akt S473, and phospho-GSK3β S9 in three indepen-
dent immunoblot experiments relative to VC. (I) Akt phospho-substrate antibody was used to probe the VC and PME-1 OE lysates. Arrows
highlight some proteins whose phosphorylation increased in PME-1 OE cells. Bracket with asterisk indicates phospho-rpS6. (J and K)
Lysates were probed for changes in p70 and p85 S6K activation and rpS6 phosphorylation. Total p70 and p85 S6K and total rpS6 were
used as controls. (L) Graph represents the average fold change in the levels of phospho-p85, phospho-p70, and phospho-rpS6 in three
immunoblot experiments relative to VC. Error bars represent SD of three independent experiments. For all graphs: *P ≤ .05. **P ≤ .01.
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dominant-negative Akt expression greatly reduced p70/p85 S6K
activation observed on LCMT-1 knockdown. However, the small
amount of residual phosphorylation on p85 S6K (P = .04 when com-
pared with control) and more substantial residual phosphorylation of
rpS6 (P = .02 when compared with control) suggest there is also more
direct, Akt-independent regulation of this pathway by methylation-
sensitive PP2A heterotrimers. Consistent with this idea, Bα-containing
PP2A heterotrimers have been reported to directly bind to and nega-
tively regulate p70 S6K [16]. Furthermore, E4orf4, an adenovirus
protein that inhibits the Bα-containing PP2A heterotrimers, increases
the level of activated p70 S6K and inhibitory phosphorylation of
4EBP1 [47], therefore likely promoting translation. Thus, whereas
Akt-dependent signaling is required for LCMT-1 knockdown to en-
hance transformation in HEKTERASB56γ cells, methylation-sensitive
PP2A heterotrimers regulate translation in both Akt-dependent and
independent manners.
Interestingly, the importance of LCMT-1 for the regulation of
Akt and p70/p85 S6K and increased growth and/or survival was re-
vealed in the current study only under anchorage-independent growth
conditions. This finding is significant considering that anchorage-
independent growth facilitated by resisting anoikis, programmed cell
death induced by detachment of cells from their extracellular matrix
(ECM), is a critical step in tumorigenesis [40]. Under anchorage-
dependent conditions, growth and survival signaling are normally ini-
tiated by the interaction of integrins with the ECM. When cells
detach from the substratum, these signals are abrogated, and cells
undergo growth arrest and anoikis. Cancer cells resist anoikis by
aberrant ECM-independent growth and survival signaling and can
proliferate and survive in anchorage-independent conditions. Inhibi-
tion of methylation-sensitive PP2A heterotrimers by LCMT-1 knock-
down may provide prosurvival and progrowth signaling normally
initiated by the interaction of integrins with the ECM. Consistent
with this idea, PP2A is involved in integrin-mediated growth and sur-
vival signaling [29,48–54]. Also, Src, a kinase that phosphorylates and
inactivates PP2A [55], functions in prosurvival integrin signaling
[40]. Importantly, inhibition of PP2A is known to cause increased
activation of Akt and p70 S6K [47,53,56,57]. Therefore, we propose
that LCMT-1 knockdown promotes anchorage-independent growth
by reducing methylation-sensitive PP2A complexes that normally
function to promote growth arrest and anoikis through inactivation
of Akt under anchorage-independent conditions. Because SVST tar-
gets methylation-sensitive B-type subunits for replacement and evades
control of heterotrimer formation by PP2Ac methylation (Figure 1),
the ability of SVST expression to induce HEKTER cells to grow in an
anchorage-independent environment may be explained in part by
these findings.
In contrast to previous results with HeLa cells where LCMT-1
knockdown induced apoptosis in a small portion of the cells
[12,31], no increase in cell death on LCMT-1 knockdown was seen
in the current study. The cell death in HeLa cells was reported to be
due at least in part to mitotic checkpoint errors [31]. Therefore, it
would not be unreasonable to expect that, with strong prosurvival
Figure 9. Proposed model for the negative regulation of anchorage-independent growth and survival by methylation-sensitive PP2A
heterotrimers and the protransformation effects of reducing these heterotrimers by SVST expression, LCMT-1 knockdown, or PME-1
overexpression. Methylation of PP2Ac through LCMT-1 promotes incorporation of methylation-sensitive B-type subunits (B*) into
heterotrimers that dephosphorylate and thereby inactivate Akt and S6K. PP2A methylation-sensitive heterotrimers can act on S6K in
both an Akt-dependent and independent manner to block downstream survival and translation signals and thus transformation.
PP2A methylation-sensitive heterotrimers also promote the dephosphorylation of rpS6 independently of S6K to block translation,
although it is not known if this is a direct or indirect effect. Methylation-insensitive SVST (or PyST and PyMT) oncoprotein replaces
methylation-sensitive B-type subunits, promoting transformation by preventing the dephosphorylation and inactivation of Akt and
S6K. Transformation is also enhanced by reducing methylation-sensitive PP2A heterotrimers by inhibition of LCMT-1 (e.g., through
shRNA or mutation) or PME-1 overexpression (PME-OE). For simplicity, only the targets of methylation-sensitive PP2A heterotrimers
examined in this study are shown in this schematic.
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signaling, these errors might not lead to death. Thus, differences in
prosurvival signaling between HeLa and HEKTERASB56γ may
explain this disparity. Consistent with this possibility, we have found
that LCMT-1 knockdown increases apoptosis in some cancer cell
lines (e.g., HeLa and H1299 cells) but not others.
PME-1 overexpression also reduced PP2Ac methylation, enhanced
transformation, and caused many of the same signaling effects as
LCMT-1 knockdown, further supporting the hypothesis that reduc-
tion in PP2Ac methylation enhances transformation through up-
regulation of Akt and p70/p85 S6K pathways. The reduced potency
of overexpressing PME-1 compared to LCMT-1 knockdown may
result from PME-1 overexpression having other effects on PP2A holo-
enzyme assembly or activity. This possibility is consistent with the
report that PME-1 functions in PP2A biogenesis [2,58], and with the
finding that PME-1 knockout in mice results in reduced PP2A activity
toward a phosphopeptide substrate and reduced total PP2A protein in
several tissues [59]. Consistent with our findings that PME-1 over-
expression promotes transformation, PME-1 was found to be over-
expressed in human gliomas and knockdown of PME-1 in HeLa cells
reduced transformation [60]. Together, these data argue strongly that
loss of PP2A methylation promotes transformation.
Consistent with the idea that MT and ST oncoproteins transform cells
in part by circumventing the normal control of PP2A by methylation,
the Akt and p70/p85 S6K pathways activated by LCMT-1 knockdown
are known to be activated by SV40- and polyomavirus-induced trans-
formation [25–27,61–66]. PyMT, PyST, and SVST have all been
reported to induce Akt phosphorylation on activating residues [25–
27,64–66], whereas PyMT and PyST have been shown to activate
the p70 S6K pathway [63,66]. Similar to our present findings, rpS6
phosphorylation induced by these viruses is likely mediated through
both Akt-dependent and Akt-independent pathways. For example,
PyMT was reported to cause p70 S6K activation and rpS6 phos-
phorylation through activation of PI3-kinase (and thus Akt) but also
to directly induce rpS6 phosphorylation independent of PI3-kinase
and p70 S6K [63]. More recent data indicate that PyST can also
enhance rpS6 phosphorylation [66].
The pathways impacted by LCMT-1 knockdown in this study are
highly relevant to human cancer. Akt activation is common in cancer
and, in many cases, correlates with a poor prognosis and resistance to
current therapies [67]. As a direct target and important effector of
mTOR in the control of cell growth and proliferation, p70 S6K
has also been implicated in tumorigenesis [46,68]. Increases in the
amount and/or activation of p70 S6K have been reported in multiple
cancers or cancer cell lines [69–73]. Therefore, the growth and sur-
vival pathways upregulated on loss of LCMT-1 are important not
only for SV40- and polyomavirus-mediated transformation but also
for human cancer. Our study also demonstrates that modulation of
PP2Ac methylation is sufficiently potent to regulate these growth and
survival pathways and that LCMT-1 is important for the tumor-
suppressive function of PP2A. On the basis of these findings, it seems
likely that down-regulation of LCMT-1 amount or activity will be
found to contribute to the development of human cancers and that com-
pounds that increase PP2A methylation (e.g., PME-1 inhibitors) will
exhibit anticancer activity.
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